Year archive

Pharming Group N.V. — 2015 filings

All 21 regulatory filings released by Pharming Group N.V. (PHARM) in 2015, sourced directly from the official regulator.

21 Filings

2015 Period

2015 filings (21)

Filing	Released	Lang
Pharming and Hyupjin Announce Receipt of the South Korean Marketing Authorisation for RUCONEST® Regulatory Filings	2015-12-21	English
European Medicines Agency Reaffirms Important Health Benefits and Safety of RUCONEST® for Patients With Hereditary Angio-edema Regulatory Filings	2015-12-07	English
Interim / Quarterly Report 2015 Interim / Quarterly Report 9M 2015	2015-10-29	English
Pharming Group NV Interim Report January - September 2015 Interim / Quarterly Report 9M 2015	2015-10-28	English
FDA Grants RUCONEST® (C1 Esterase Inhibitor [Recombinant]) Twelve-Year Reference Product Exclusivity Regulatory Filings	2015-10-08	English
Pharming Nominates Mr Robin Wright as Chief Financial Officer Board/Management Information	2015-09-08	English
Interim / Quarterly Report 2015 Interim / Quarterly Report H1 2015	2015-07-30	English
Pharming Reports on Financial Results First Half Year 2015 Interim / Quarterly Report H1 2015	2015-07-30	English
HAEi Global Access Program for RUCONEST® Now Live Regulatory Filings	2015-07-21	English
PHARMING ANNOUNCES US$17 MILLION (€15.6 MILLION) STRAIGHT DEBT FINANCING Capital/Financing Update	2015-07-20	English
Pharming Announces Interim Results From the Ongoing Phase II Pediatric Clinical Trial of RUCONEST Earnings Release H1 2015	2015-06-01	English
Pharming and Cytobioteck Announce Distribution Agreement for Ruconest Environmental & Social Information	2015-05-26	English
Pharming and Clinigen Group Initiate "HAEi GAP" Global Access Program for RUCONEST® Investor Presentation	2015-05-18	English
Pharming Reports on Annual General Meeting of Shareholders Regulatory Filings	2015-05-01	English
Interim / Quarterly Report 2015 Interim / Quarterly Report Q1 2015	2015-04-30	English
Pharming Reports on Financial Results for Q1 2015 Interim / Quarterly Report Q1 2015	2015-04-30	English
Pharming Nominates Paul Sekhri and Jan Egberts as Members of its Board of Supervisory Directors Board/Management Information	2015-03-19	English
Annual Report 2014 Annual Report FY 2014	2015-03-19	English
Pharming Reports on Preliminary Financial Results 2014 Earnings Release FY 2014	2015-03-05	English
Pharming Appoints Dr. Perry Calias as Chief Scientific Officer Board/Management Information	2015-02-18	English
Pharming and Salix Announce First Patient Treated in Clinical Study of Ruconest® for Prophylaxis of Hereditary Angioedema Regulatory Filings	2015-01-08	English

Filings by year

2026 29 filings
2025 60 filings
2024 60 filings
2023 64 filings
2022 56 filings
2021 48 filings
2020 44 filings
2019 17 filings
2018 18 filings
2017 22 filings
2016 25 filings
2015 21 filings
2014 19 filings
2013 26 filings
2012 59 filings
2011 34 filings
2010 52 filings
2009 40 filings
2008 29 filings
2007 44 filings
2006 23 filings
2005 6 filings